Have a Claim?

Click here for a confidential contact or call:


December 2, 2013

Posted  January 22, 2016

Caremark agreed to pay $4.25M to settle allegations that it knowingly failed to reimburse Medicaid for prescription drug costs paid on behalf of Medicaid beneficiaries, who also were eligible for drug benefits under Caremark-administered private health plans. The allegations were first raised in a qui tam lawsuit filed under the whistleblower provisions of the False Claims Act. DOJ

Tagged in: Drug and DME Pricing, FCA Federal, Medicaid, Pharma Fraud, Whistleblower Case,